These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009]. Rosenthal E; Delaunay P; Jeandel PY; Haas H; Pomares-Estran C; Marty P Med Mal Infect; 2009 Oct; 39(10):741-4. PubMed ID: 19783391 [TBL] [Abstract][Full Text] [Related]
5. Costs of amphotericin B lipid complex for kala-azar. Basnyat B Ann Intern Med; 1998 Feb; 128(4):326. PubMed ID: 9471948 [No Abstract] [Full Text] [Related]
7. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Thakur CP; Dedet JP; Narain S; Pratlong F Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558 [TBL] [Abstract][Full Text] [Related]
9. Chronic diarrhea and malabsorption caused by Leishmania donovani. Baba CS; Makharia GK; Mathur P; Ray R; Gupta SD; Samantaray JC Indian J Gastroenterol; 2006; 25(6):309-10. PubMed ID: 17264434 [TBL] [Abstract][Full Text] [Related]
10. Treatment options for visceral leishmaniasis. den Boer M; Davidson RN Expert Rev Anti Infect Ther; 2006 Apr; 4(2):187-97. PubMed ID: 16597201 [TBL] [Abstract][Full Text] [Related]
11. [Diarrhea due to visceral leishmaniasis in a liver transplant recipient]. Vargas Acosta AM; Belchí Segura E; Martinez Caselles A; Baños Madrid R; Pons Miñano JA; Parrilla Paricio P Gastroenterol Hepatol; 2013 Apr; 36(4):271-3. PubMed ID: 23453560 [No Abstract] [Full Text] [Related]
12. [A case of antimony resistant kala-azar cured with amphotericin B]. Chen SB; Yang CM; Zhang CJ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767 [No Abstract] [Full Text] [Related]
13. Current issues in the treatment of visceral leishmaniasis. Bryceson A Med Microbiol Immunol; 2001 Nov; 190(1-2):81-4. PubMed ID: 11770117 [No Abstract] [Full Text] [Related]
15. Visceral leishmaniasis: a trip to the Greek Islands is not always idyllic. Ju O; Grove DI; Jaksic WJ; Dart GW Med J Aust; 2004 Oct; 181(8):446-7. PubMed ID: 15487964 [TBL] [Abstract][Full Text] [Related]
16. [Visceral leishmaniasis refractory to treatment: the efficacy of amphotericin B]. Pérez Brea A; Ruiz Moreno M; Leal Orozco A; Escorihuela Esteban R; Otero Fraguas M An Esp Pediatr; 1996 Feb; 44(2):161-3. PubMed ID: 8830578 [No Abstract] [Full Text] [Related]
17. Progress in the treatment of a neglected infectious disease: visceral leishmaniasis. Murray HW Expert Rev Anti Infect Ther; 2004 Apr; 2(2):279-92. PubMed ID: 15482193 [TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative. Gómez Campderá F; Berenguer J; Anaya F; Rodriguez M; Valderrábano F Am J Nephrol; 1998; 18(2):171. PubMed ID: 9569963 [No Abstract] [Full Text] [Related]
19. Migration of Leishmania donovani amastigotes in the cerebrospinal fluid. Prasad LS; Sen S Am J Trop Med Hyg; 1996 Dec; 55(6):652-4. PubMed ID: 9025693 [TBL] [Abstract][Full Text] [Related]
20. Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovani. Petit C; Yardley V; Gaboriau F; Bolard J; Croft SL Antimicrob Agents Chemother; 1999 Feb; 43(2):390-2. PubMed ID: 9925541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]